| Identification | Back Directory | [Name]
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine | [CAS]
477600-69-4 | [Synonyms]
-N,4-dimethyL
(3R,4R)-1-BenzyL
Tofacitinib Impurity 66
Tofacitib impurity SM2-G
Tofacitinib Related Compound 38
cis-1-Benzyl-N,4-diMethylpiperidin-3-aMine
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine (rel)
rel-((3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine)
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine.D-PTTA
(3S,4S)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine
(3S,4S)-(1-Benzyl-4-methyl-piperidin-3-yl)-methyl-amine
3-piperidinaMine, N,4-diMethyl-1-(phenylMethyl)-, (3S,4S)-
(3R,4R)-rel-N,4-Dimethyl-1-(phenylmethyl)-3-Piperidinamine
3-PiperidinaMine, N,4-diMethyl-1-(phenylMethyl)-, (3R,4R)-rel- | [EINECS(EC#)]
1312995-182-4 | [Molecular Formula]
C14H22N2 | [MOL File]
477600-69-4.mol | [Molecular Weight]
218.34 |
| Chemical Properties | Back Directory | [Boiling point ]
302.6±35.0 °C(Predicted) | [density ]
1.00±0.1 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2–8 °C | [pka]
10.26±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine is a reagent used in the preparation of substituted pyrrrolipyrimidinamines as Januus kinase inhibitors (CP-352,664), for the treatment of autoimmune diseases and organ transplant rejection. |
|
|